Roxana Reyes
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Bone health and treatments
- COVID-19 and healthcare impacts
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 7
- Pleural and Pulmonary Diseases 2
- Oncology 11
- Cancer Immunotherapy and Biomarkers 4
- COVID-19 and healthcare impacts 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Noemı́ Reguart (15 shared papers)Cristina Teixidó (10 shared papers)Noelia Vilariño (1 shared paper)François Lanza (1 shared paper)D.Y. Graham (1 shared paper)Hillel T. Schwartz (1 shared paper)Hui Quan (1 shared paper)Hoda M. Malaty (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Journal of Thoracic Oncology (2 papers)Cancers (2 papers)Clinical & Translational Oncology (1 paper)Drugs (1 paper)
- Partner nations
- SpainFranceUnited States
In The Last Decade
Roxana Reyes
19 papers receiving 298 citations
Peers
Comparison fields: 5 of 58
- Oncology 211
- Pulmonary and Respiratory Medicine 161
- Orthopedics and Sports Medicine 36
- Cancer Research 40
- Immunology 32
Countries citing papers authored by Roxana Reyes
This map shows the geographic impact of Roxana Reyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Reyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Reyes more than expected).
Fields of papers citing papers by Roxana Reyes
This network shows the impact of papers produced by Roxana Reyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Reyes. The network helps show where Roxana Reyes may publish in the future.
Co-authors
The 25 scholars most cited alongside Roxana Reyes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 122 | |
| 2 | 2000 | 48 | |
| 3 | 2021 | 27 | |
| 4 | 2021 | 21 | |
| 5 | 2019 | 15 | |
| 6 | 2020 | 14 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 12 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 3 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2021 | 2 | |
| 17 | Serologic classification of acute viral hepatitis at San Lazaro Hospital, Manila, Philippines. | 1990 | 2 |
| 18 | 2021 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2025 | 0 |
About Roxana Reyes
Roxana Reyes is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Epidemiology, having authored 22 papers that have together received 307 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), COVID-19 and healthcare impacts (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Pleural and Pulmonary Diseases (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Oncology (211 citations), Pulmonary and Respiratory Medicine (161 citations), Orthopedics and Sports Medicine (36 citations), Cancer Research (40 citations) and Immunology (32 citations). Roxana Reyes has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Noemı́ Reguart, Cristina Teixidó, Noelia Vilariño, François Lanza, D.Y. Graham, Hillel T. Schwartz, Hui Quan, Hoda M. Malaty, Núria Viñolas and Iván Vollmer. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Cancers, Clinical & Translational Oncology and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.